These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2463252)

  • 1. Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that the protein is vitronectin.
    Mimuro J; Loskutoff DJ
    J Biol Chem; 1989 Jan; 264(2):936-9. PubMed ID: 2463252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma.
    Wiman B; Almquist A; Sigurdardottir O; Lindahl T
    FEBS Lett; 1988 Dec; 242(1):125-8. PubMed ID: 2462509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of the interaction between type 1 plasminogen activator inhibitor and vitronectin and evidence that the bovine inhibitor binds to a thrombin-derived amino-terminal fragment of bovine vitronectin.
    Seiffert D; Loskutoff DJ
    Biochim Biophys Acta; 1991 May; 1078(1):23-30. PubMed ID: 1710930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity purification of active plasminogen activator inhibitor-1 (PAI-1) using immobilized anhydrourokinase. Demonstration of the binding, stabilization, and activation of PAI-1 by vitronectin.
    Wun TC; Palmier MO; Siegel NR; Smith CE
    J Biol Chem; 1989 May; 264(14):7862-8. PubMed ID: 2470735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of high and low molecular weight plasminogen activator inhibitor 1 from fibrosarcoma cell-line HT 1080 conditioned medium.
    Lindahl T; Wiman B
    Biochim Biophys Acta; 1989 Feb; 994(3):253-7. PubMed ID: 2493266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin).
    Declerck PJ; De Mol M; Alessi MC; Baudner S; Pâques EP; Preissner KT; Müller-Berghaus G; Collen D
    J Biol Chem; 1988 Oct; 263(30):15454-61. PubMed ID: 2459123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for the extracellular interaction of plasminogen activator inhibitor 1 with endothelial cell matrix-associated vitronectin.
    Preissner KT; Grulich-Henn J; Ehrlich HJ; Declerck P; Justus C; Collen D; Pannekoek H; Müller-Berghaus G
    J Biol Chem; 1990 Oct; 265(30):18490-8. PubMed ID: 1698787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of type 1 plasminogen activator inhibitor to the extracellular matrix of cultured bovine endothelial cells.
    Mimuro J; Loskutoff DJ
    J Biol Chem; 1989 Mar; 264(9):5058-63. PubMed ID: 2494180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of plasminogen activator inhibitor-2 (PAI-2) from human placenta. Evidence for vitronectin/PAI-2 complexes in human placenta extract.
    Radtke KP; Wenz KH; Heimburger N
    Biol Chem Hoppe Seyler; 1990 Dec; 371(12):1119-27. PubMed ID: 1708670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.
    Seiffert D; Wagner NN; Loskutoff DJ
    J Cell Biol; 1990 Sep; 111(3):1283-91. PubMed ID: 1697297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a discrete binding protein of plasminogen activator inhibitor in plasma.
    Wiman B; Lindahl T; Almqvist A
    Thromb Haemost; 1988 Jun; 59(3):392-5. PubMed ID: 3142076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The primary plasminogen-activator inhibitors in endothelial cells, platelets, serum, and plasma are immunologically related.
    Erickson LA; Hekman CM; Loskutoff DJ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8710-4. PubMed ID: 3936043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of binding sites for heparin, plasminogen activator inhibitor-1, and plasminogen to vitronectin's heparin-binding region reveals a novel vitronectin-dependent feedback mechanism for the control of plasmin formation.
    Kost C; Stüber W; Ehrlich HJ; Pannekoek H; Preissner KT
    J Biol Chem; 1992 Jun; 267(17):12098-105. PubMed ID: 1376317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that type 1 plasminogen activator inhibitor binds to the somatomedin B domain of vitronectin.
    Seiffert D; Loskutoff DJ
    J Biol Chem; 1991 Feb; 266(5):2824-30. PubMed ID: 1704366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.
    van Mourik JA; Lawrence DA; Loskutoff DJ
    J Biol Chem; 1984 Dec; 259(23):14914-21. PubMed ID: 6438106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of recombinant plasminogen activator inhibitor-1 from Escherichia coli.
    Reilly TM; Seetharam R; Duke JL; Davis GL; Pierce SK; Walton HL; Kingsley D; Sisk WP
    J Biol Chem; 1990 Jun; 265(16):9570-4. PubMed ID: 2188980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin.
    Ehrlich HJ; Keijer J; Preissner KT; Gebbink RK; Pannekoek H
    Biochemistry; 1991 Jan; 30(4):1021-8. PubMed ID: 1703436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between type 1 plasminogen activator inhibitor, extracellular matrix and vitronectin.
    Seiffert D; Mimuro J; Schleef RR; Loskutoff DJ
    Cell Differ Dev; 1990 Dec; 32(3):287-92. PubMed ID: 1711915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of active human plasminogen activator inhibitor 1 from Escherichia coli. Comparison with natural and recombinant forms purified from eucaryotic cells.
    Lawrence D; Strandberg L; Grundström T; Ny T
    Eur J Biochem; 1989 Dec; 186(3):523-33. PubMed ID: 2514093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.
    Hekman CM; Loskutoff DJ
    J Biol Chem; 1985 Sep; 260(21):11581-7. PubMed ID: 3930479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.